AERIE PHARMACEUTICALS INC - COM (AERI)

Q1 2016 13F Holders as of 31 Mar 2016

Type / Class
Equity / COM
Number of holders
100
Total 13F shares, excl. options
26,614,668
Shares change
+2,304,942
Total reported value, excl. options
$323,615,000
Value change
+$7,011,091
Put/Call ratio
71%
Number of buys
59
Number of sells
-42
Price
$12.16

Significant Holders of AERIE PHARMACEUTICALS INC - COM (AERI) as of Q1 2016

124 filings reported holding AERI - AERIE PHARMACEUTICALS INC - COM as of Q1 2016.
AERIE PHARMACEUTICALS INC - COM (AERI) has 100 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 26,614,668 shares .
Largest 10 shareholders include JENNISON ASSOCIATES LLC (3,690,190 shares), WELLINGTON MANAGEMENT GROUP LLP (3,037,983 shares), DEERFIELD MANAGEMENT CO (2,632,482 shares), Partner Fund Management, L.P. (2,381,135 shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (2,025,000 shares), TPG Group Holdings (SBS) Advisors, Inc. (1,237,466 shares), Foresite Capital Management III, LLC (957,126 shares), Foresite Capital Management II, LLC (949,372 shares), VANGUARD GROUP INC (905,907 shares), and BlackRock Fund Advisors (879,783 shares).
This table shows the top 100 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.